Kalinox

Nitrous oxide and oxygen, the active ingredient in Kalinox, is an analgesic/anesthetic gas presented as a medical gas for inhalation use. It provides analgesia and anxiolysis during minor procedures and supplies supplemental oxygen to support ventilation.

GNH USA supplies Kalinox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and surgical centres worldwide.

Kalinox, a nitrous oxide/oxygen mixture, is used within the analgesic and anesthetic pathway for procedural sedation.

- Minor surgical procedures: delivers rapid analgesia and anxiolysis during brief operations. - Diagnostic procedures: reduces pain and discomfort during endoscopy, dental work and other minor investigations. - Adjunct to general anesthesia: supplies supplemental oxygen and maintains analgesic effect during induction and maintenance of anesthesia.

Common side effects are generally mild and transient.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Vomiting: occasional emesis during or after administration. - Dizziness: transient light‑headedness. - Headache: mild headache after exposure. - Dry mouth: reduced salivation. - Euphoria: brief feeling of well‑being.

Serious or Rare Side Effects: - Hypoxia: reduced blood oxygen levels if oxygen supply is inadequate. - Respiratory depression: slowed breathing requiring monitoring. - Loss of consciousness: rare but possible with excessive dosing. - Severe hypotension: marked drop in blood pressure. - Allergic reaction: rash, itching or swelling. - Pulmonary edema: fluid accumulation in lungs in extreme cases.

When using Kalinox, careful assessment and monitoring are essential to ensure patient safety.

- Patient assessment: evaluate respiratory status and contraindications before administration. - Contraindications: avoid in patients with severe COPD, pneumothorax, or known vitamin B12 deficiency. - Equipment check: ensure proper scavenging and delivery system integrity. - Monitoring: continuously observe oxygen saturation, heart rate and level of consciousness. - Pregnancy and lactation: use only if benefit outweighs potential risk, as safety data are limited. - Storage: Store at ambient temperature: keep cylinder upright, protect from heat and direct sunlight.

Kalinox may interact with other agents that affect the central nervous system or respiratory function.

Major Interactions (Avoid): - Other inhalational anesthetics: may potentiate respiratory depression. - Sedatives or hypnotics: increase risk of excessive sedation. - Alcohol: additive depressant effect on CNS. - Opioids: may enhance respiratory depression. - Nitrites: can cause severe hypotension.

Moderate Interactions (Monitor Closely): - Benzodiazepines: may require dose adjustment. - MAO inhibitors: monitor for heightened cardiovascular effects. - Antidepressants (SSRIs/SNRIs): watch for serotonin syndrome signs. - Antihypertensives: potential additive blood pressure lowering. - Anticholinergics: may exacerbate dry mouth.